CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 75 filers reported holding CYTEK BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,295,847 | -44.6% | 420,749 | -20.2% | 0.22% | -50.6% |
| Q3 2022 | $7,760,000 | +51.6% | 527,164 | +10.5% | 0.45% | +51.2% |
| Q2 2022 | $5,120,000 | +11.9% | 477,164 | +12.4% | 0.30% | +100.7% |
| Q1 2022 | $4,577,000 | -33.5% | 424,577 | +0.7% | 0.15% | -40.6% |
| Q4 2021 | $6,883,000 | -27.7% | 421,777 | -5.1% | 0.25% | -14.1% |
| Q3 2021 | $9,514,000 | – | 444,368 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |